Finnrick - Ensuring a Safer and More Transparent Supply Chain
Peptide Haven

Peptide Haven

Tirzepatide

Finnrick tested 2 samples of Tirzepatide (GLP-1 and GIP agonist) from Peptide Haven on 2 Dec 2025. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).

Finnrick Rating™
Tentative Rating
Peptide Haven
Tirzepatide
Tested 2 Samples
Last test 2 Dec 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Peptide Haven

Samples are tested in commercial labs

Tests Count

2

Scores

AVG7.2MIN5.9MAX8.4

Last

2 Dec 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
2 Dec 2025View5.910mg8.24mg-17.6%99.30%TZP10-0825-A White Label / Copper Crimp / Clear CapLab GVendor
2 Dec 2025View8.410mg10.5mg+5.0%99.20%TZP10-0825-A White Label / Copper Crimp / Clear CapLab GVendor

Launch with Finnrick

Some of the samples listed on this page were submitted by their vendor, as part of the Launch with Finnrick vendor support program.

The program is designed to help vendors get listed on the Finnrick web site while protecting the integrity of our rating system.

The vendor submitted four samples per product, two of which were tested by Finnrick for identity, purity and quantity according to our usual process. The vials were anonymized before being sent to the testing lab.